GRANULES IS MOVING IN AN UPWARD CHANNEL.
TRADING ABOVE 103.8 IS IMPORTANT FOR TARGETS OF 108 AND 112.
I DO NOT UNDERSTAND IN THE CASE OF GRANULES, "WHY ANY +VE NEWS IS NOT +VE?".
PROMOTER HAD REDUCED HIS PLEDGED SHARES, SINGAPORE SISTER CONCERN SOLD, RESULTS ARE GOOD, ETC.
NSE:GRANULES
Only for education and information purpose. Should not be taken as a trading call
An entry and be taken at D point
CHART BY HARMONIC LEARNING AND EARNING
GRANULES CLOSED ABOVE THE DOJI BY COMING ABOVE THE TREND LINE.
ALSO, AN INVERSE H&S FORMATION IS OBSERVED WITH NECK LINE AT 102.
NEXT TARGET IS EXPECTED AS 102.
RESULTS ARE GOOD AND CNX PHARMA ALSO LOOKING BULLISH. LET US SEE.
GRANULES MAY GO DOWN TO 102 AT THE LEAST.
LOOK AT THE HIGH DELIVERY PERCENTAGES OF 55%+ EVERY DAY.
THIS INDICATES SOME BIG ONE IS ACCUMULATING AT THESE LEVELS.
IT IS A PRACTICE BY THEM TO ACQUIRE AT LOWER LEVELS AND THEY SEE IT THAT ALWAYS THE PRICE GOES DOWN TILL THEIR REQUIREMENT IS MET.
THIS ENSURES THAT WEEK HANDS GIVES AWAY AND MORE SHARES ARE AVAILABLE...
Bullish Bat pattern on 4H Chart of Granules India. BUY 113-113.1.
[i[I just started learning Harmonics, so I don't know how to calculate Target(s) & SL, yet.
AS PER MY 6TH APRIL POST ON GRANULES, IT HAD TOUCHED 120 TODAY.
EVERYTHING REMAINS SAME AS FAR AS TARGETS ARE CONCERNED.
IN ADDITION, WE HAVE BUY SIGNAL IN DAY CHART.
AND, MONEY HAS STARTED ENTERING INTO BUYING.
ALL THE BEST!!
THERE IS LOT OF INTERESTING OBSERVATIONS IN GRANULES CHART (MARKED BLUE).
THERE IS A HAMMER FORMED AT 110 LEVEL ON 4TH APRIL AT THE BOTTOM OF THE FALL.
THE SCRIP SHOULD CROSS 121 INITIALLY AND MOVE TOWARDS 130 (T-1) AND 140 (T-2).
STOP LOSS CAN BE PLACED AT 105.
There is Japanese Proverb " A Fool in hurry drinks tea with chopsticks " if you think its going up , watch out its due for correction
Look for investment opportunity after this correction it will likely move up for Good % Gain move
Good Luck
Short Granules with a target of 95 with a stop loss of 108. Then it should cross 107/123, from there. Inverted head and shoulders is observed with neck line at 107.
Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The Company's business operations include three areas: core business, emerging business, and contract research and manufacturing services (CRAMS). Its products in Core business include Paracetamol, Ibuprofen, Guaifenesin and Metformin. The Company operates a healthcare division, Granules Consumer Healthcare (GCH). The Company, through an acquisition, has access to over 10 APIs, as well as intermediates in therapeutic categories, such as anti-histaminic, antihypertensive and anti-convulsants. The Company's PFI products include Compresso PAP 97 S, Compresso PAP 90 CPC and Paracetamol Caffeine Combo 77.4. The Company's FDs include Paracetamol/Acetaminophen, and Acetaminophen and Methocarbamol.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
GRANULES
